Online Program

288980
Effects of ethnicity, race, and income on the stage of breast cancer at diagnosis among women in south Florida


Sunday, November 3, 2013

Mary Garland, Division of Research and Information and Data Coordinating Center, Florida International University Herbert Wertheim College of Medicine, Miami, FL
Kailee Imperatore, Division of Research and Information and Data Coordinating Center, Florida International University Herbert Wertheim College of Medicine, Miami, FL
Juan Lozano, MD., MSc, Division of Research and Information and Data Coordinating Center, Florida International University Herbert Wertheim College of Medicine, Miami, FL
Juan Acuna, MD., MSc., FACOG, Division of Research and Information and Data Coordinating Center, Florida International University Herbert Wertheim College of Medicine, Miami, FL
Grettel Castro, MPH, Division of Research and Information and Data Coordinating Center, Florida International University Herbert Wertheim College of Medicine, Miami, FL
Pura Rodriguez, MPH, Division of Research and Information and Data Coordinating Center, Florida International University Herbert Wertheim College of Medicine, Miami, FL
Rakesh Ravikumaran Nair, MD., MPH., CHES, Division of Research and Information and Data Coordinating Center, Florida International University Herbert Wertheim College of Medicine, Miami, FL
Background: Previous research showed that Hispanic and Black women present with later stage breast cancer than do Non-Hispanic Whites.

Objective: To determine if Hispanic and Black women in South Florida present with later stage breast cancer than Non-Hispanic Whites.

Method: Secondary analysis of the effects of ethnicity, race, and income on breast cancer stage at diagnosis using the Florida Cancer Registry (2006-2009) was performed. Women 18 years and older at the first presentation of primary breast cancer were included with outcomes being Early (0, I or II) versus late (II or IV) stage at diagnosis. Univariate associations between independent and dependent variables were tested using Chi-Square. Adjusted associations with all variables were estimated with logistic regression.

Results: 12,899 out of 13,669 women had stage reported. Late stage breast cancer was found in 11.5%. Women were 82.0% Whites, 18.0% Blacks, 61.5% Non-Hispanics, and 38.5% Hispanics. Most women were from high middle income level (41.1%) or high income level (26.5%). Most women were aged 50-74 (53.8%), followed by 18-49 (25.8%). No associations found between stage and race [adjusted Odds Ratio (aOR) 1.03, 95% CI 0.09-1.21], ethnicity (aOR 0.99, 95% CI 0.87-1.13), or income level (Low: aOR 0.95, 95% CI 0.77-1.16; High middle: aOR 1.02, 95% CI 0.09-1.18).

Conclusions: Our data showed no association between ethnicity, race, and income and breast cancer stage at diagnosis. South Florida Blacks are frequently of Caribbean heritage and the Hispanic population is dominated by Puerto Rican, Cubans, and Dominicans rather than Mexicans.

Learning Areas:

Administer health education strategies, interventions and programs
Basic medical science applied in public health
Chronic disease management and prevention
Clinical medicine applied in public health
Diversity and culture
Provision of health care to the public

Learning Objectives:
Identify if Hispanic and Black women in South Florida present with later stage breast cancer than Non-Hispanic Whites. Evaluate the predictors of late stage Breast cancer presentation among South Florida Women’s

Keyword(s): Breast Cancer, Ethnic Minorities

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have participated in multiple research endeavors at the Florida International University Herbert Wertheim College of Medicine as a principal or co-principal investigator. Among my research interest are community-based participatory research and applied biostatistics.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.